<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01676454</url>
  </required_header>
  <id_info>
    <org_study_id>Vasopressin Study</org_study_id>
    <nct_id>NCT01676454</nct_id>
  </id_info>
  <brief_title>Serum Vasopressin Levels and Severe Hemorrhagic Shock</brief_title>
  <official_title>Determination of Serum Vasopressin Levels and Correlation With Life-threatening Complications in Adults With Severe Hemorrhagic Shock.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poudre Valley Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poudre Valley Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if vasopressin is used up by the body during&#xD;
      traumatic shock (severe low blood pressure due to trauma).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For humans suffering trauma and severe hemorrhagic shock, no randomized controlled studies of&#xD;
      the effect of exogenous vasopressin use exist, although case reports have suggested it may be&#xD;
      of benefit. Even some moribund patients with &quot;irreversible&quot; shock survived severe hemorrhagic&#xD;
      shock after administration of vasopressin. This suggests that at least some patients&#xD;
      suffering severe trauma could benefit from AAVP administration. Recently, many clinicians and&#xD;
      notable research consortiums have suggested that AVP shows promise for human resuscitation&#xD;
      and have called for further human studies.&#xD;
&#xD;
      This is a prospective, single-center observational study designed to evaluate (1) whether&#xD;
      vasopressin is depleted in severe, but not minor, trauma; and (2) the degree to which&#xD;
      endogenous vasopressin levels predict the occurrence of ARDS, sepsis, or death. To test the&#xD;
      first hypothesis, serum vasopressin levels (continuous independent variable) will be assessed&#xD;
      at enrollment (time 0), 6, 12, 18, and 24 hours later, and correlated with the two levels of&#xD;
      trauma (categorical dependent variable). To test the second hypothesis, serum vasopressin&#xD;
      levels (now a continuous dependent variable) will be correlated with each of three&#xD;
      outcomes-death, ARDS, and sepsis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Study closed without enrollment .&#xD;
  </why_stopped>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Serum vasopressin levels.</measure>
    <time_frame>24 hours.</time_frame>
    <description>6 mL's per blood draw for 5 timepoints=30 mL's total blood drawn.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Injury</condition>
  <arm_group>
    <arm_group_label>Vasopressin levels.</arm_group_label>
    <description>Cohort will consist of subjects with a minor injury or injuries defined as:&#xD;
no episodes of systolic blood pressure &lt; 90 mmHg between occurrence of injury and admission;&#xD;
no blood transfusion requirement;&#xD;
base deficit &lt; 5 mEq/L;&#xD;
no requirement for mechanical ventilation other than transiently during orthopedic surgery.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to Medical Center of the Rockies with minor injuries.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients with a minor injury or injuries, defined as:&#xD;
&#xD;
          1. no episodes of systolic blood pressure &lt; 90 mmHg between occurrence of injury and&#xD;
             admission;&#xD;
&#xD;
          2. no blood transfusion requirement;&#xD;
&#xD;
          3. base deficit &lt; 5 mEq/L;&#xD;
&#xD;
          4. no requirement for mechanical ventilation other than transiently during orthopedic&#xD;
             surgery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnancy&#xD;
&#xD;
          2. corticosteroid use,&#xD;
&#xD;
          3. prisoners, and/or&#xD;
&#xD;
          4. head trauma as determined by computed tomography (head trauma may itself induce&#xD;
             diabetes insipidus, a marker of pituitary damage and vasopressin deficiency), and/or&#xD;
&#xD;
          5. evidence of spinal cord injury (another cause of vasodilatory shock).&#xD;
&#xD;
        Patients will also be excluded if pre-hospital provider information cannot be obtained, or&#xD;
        indicates that the trauma occurred more than one 1 hour prior to emergency department&#xD;
        admission.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julie Dunn, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Poudre Valley Health System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical Center of the Rockies</name>
      <address>
        <city>Loveland</city>
        <state>Colorado</state>
        <zip>80538</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://pvhs.org/research</url>
    <description>System website</description>
  </link>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>August 21, 2012</study_first_submitted>
  <study_first_submitted_qc>August 30, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2012</study_first_posted>
  <last_update_submitted>May 24, 2018</last_update_submitted>
  <last_update_submitted_qc>May 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Poudre Valley Health System</investigator_affiliation>
    <investigator_full_name>Julie Dunn, M.D.</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Vasopressin</keyword>
  <keyword>Trauma</keyword>
  <keyword>Injury</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Hemorrhagic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

